See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / Lukas Schmidt

Author: Lukas Schmidt
07:46am, Wednesday, Mar 25, 2026
Merck Seals $6.7B Deal to Acquire Terns Pharmaceuticals and Boosts Oncology Pipeline
Merck is set to acquire Terns Pharmaceuticals for $6.7 billion, enhancing its oncology portfolio with TERN-701, a promising drug candidate targeting chronic myeloid leukemia.
Read More